Use of genomic testing and ketongenic compounds for treatment of reduced cognitive function

摘要

H:/aarVntenvve/NR oibDCCAARX964229_1,do-10/120l14 This invention relates to methods of using genotyping to select patients for treatment with compounds capable of elevating ketone body concentrations in amounts effective to treat reduced cognitive function associated with reduced neuronal metabolism, for example, Alzheimer's disease. 40b